Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Research Institute of the McGill University Health Centre

$902,111.00

Characterization of the TGFß microRNAome - implications for new biomarkers and therapeutic targets in human cancer

FY 2015-16

Summary
Proteins are synthesized as a result of gene expression and play a critical role in maintaining normal cell function. When expression of proteins is deregulated, diseases such as cancer can arise. We focus on the action of microRNAs (miRNAs), which are micromolecules naturally synthesized by the body and capable of regulating the production of a large proportion of proteins. MicroRNAs are interesting because given the nature of their structure, they are easy to synthesize in a laboratory setting and non-toxic to cells, hence offer a valuable therapeutic option. TGFß is a growth factor capable of promoting or inhibiting critical miRNAs. Indeed, we found that when we expose a cell to TGFß, the expression of these miRNAs changes, and that as a consequence, the expression pattern of proteins within the cell will also change. Interestingly, TGFß can prevent the formation of tumors in healthy cells and early cancers, and promote metastasis (i.e. cancer dissemination) in more advanced cancer cases. With our current research, we want to identify the miRNAs that are regulated by TGFß, and investigate how modulating their expression affects tumor suppression and progression. With our newly acquired knowledge, we will determine if the abundance of our identified miRNAs is of relevance in differentiating between normal versus tumor tissue and between different types of tumors, and if they can be an indication of prognosis or response to treatment. Furthermore, we will investigate their ability to refrain tumor development, growth, and dissemination in live organisms.
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
346700
Name
Lebrun Jean-Jacques
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Characterization of the TGFß microRNAome - implications for new biomarkers and therapeutic targets in human cancer
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$902,111
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Apoptosis/Autophagy; Biomarkers; Breast Cancer; Cancer Metastasis; Hepatocarcinoma; Micrornas; Preclinical Mice Models; Tgfb Signaling; Therapeutic Targets; Tumor Suppression
Abstract
Proteins are synthesized as a result of gene expression and play a critical role in maintaining normal cell function. When expression of proteins is deregulated, diseases such as cancer can arise. We focus on the action of microRNAs (miRNAs), which are micromolecules naturally synthesized by the body and capable of regulating the production of a large proportion of proteins. MicroRNAs are interesting because given the nature of their structure, they are easy to synthesize in a laboratory setting and non-toxic to cells, hence offer a valuable therapeutic option. TGFß is a growth factor capable of promoting or inhibiting critical miRNAs. Indeed, we found that when we expose a cell to TGFß, the expression of these miRNAs changes, and that as a consequence, the expression pattern of proteins within the cell will also change. Interestingly, TGFß can prevent the formation of tumors in healthy cells and early cancers, and promote metastasis (i.e. cancer dissemination) in more advanced cancer cases. With our current research, we want to identify the miRNAs that are regulated by TGFß, and investigate how modulating their expression affects tumor suppression and progression. With our newly acquired knowledge, we will determine if the abundance of our identified miRNAs is of relevance in differentiating between normal versus tumor tissue and between different types of tumors, and if they can be an indication of prognosis or response to treatment. Furthermore, we will investigate their ability to refrain tumor development, growth, and dissemination in live organisms.
Competitiondate
201603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Lebrun, Jean-Jacques
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $902,111~ $0~